How to read and understand and use systematic reviews and meta-analyses

Acta Psychiatrica Scandinavica

Volumn 119, Issue 6, 2009, Pages 443-450

  Leucht, S ^a   Kissling, W ^a   Davis, J M ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Evaluation; Meta analysis; Psychopharmacology; Systematic review

Indexed keywords

DATA EXTRACTION; DATA SYNTHESIS; EVALUATION; INFORMATION RETRIEVAL; META ANALYSIS; METHODOLOGY; PRIORITY JOURNAL; PUBLICATION; READING; SCIENTIFIC LITERATURE; SHORT SURVEY; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; THERAPY;

BIBLIOMETRICS; EVALUATION STUDIES AS TOPIC; HUMANS; JOURNAL IMPACT FACTOR; META-ANALYSIS AS TOPIC; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REVIEW LITERATURE AS TOPIC; STATISTICS AS TOPIC; TERMINOLOGY AS TOPIC;

EID: 65749108854     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01388.x     Document Type: Short Survey

References (33)

1. Davis JM. Overview: maintenance therapy in psychiatry. I. Schizophrenia. Am J Psychiatry 1975 132 : 1237 1245.
2. Glass GV. Primary, secondary, and meta-analysis of research. Educ Res 1976 5 : 3 8.
3. Cochrane AL. 1931-1971: a critical review, with particular reference to the medical profession in Medicines for the year 2000. London : Office of Health Economics, 1979.
4. Adams CE, Power A, Frederick K, Lefebvre C. An investigation of the adequacy of MEDLINE searches for randomized controlled trials (RCTs) of the effects of mental health care. Psychol Med 1994 24 : 741 748. (Pubitemid 24265757)
5. Rosenthal R. Meta-analytic procedures for social research, Vol. 6, 2nd edn. New York : Sage Publications, 1991.
6. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B. Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 2003 326 : 1171 1173. (Pubitemid 36649049)
7. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008 358 : 252 260.
8. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997 315 : 629 634. (Pubitemid 27387172)
9. Heres S, Wagenpfeil S, Hamann J, Kissling W, Leucht S. Language bias in neuroscience - is the Tower of Babel located in Germany? Eur Psychiatry 2004 19 : 230 232. (Pubitemid 38766138)
10. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999 354 : 1896 1900.
11. Jadad A, Moore A, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996 17 : 1 12. (Pubitemid 26120810)
12. Higgins JPT, Green S. Cochrane Handbook for Systematic reviews of Interventions 4.2.5 in the Cochrane Library. Chichester : Wiley and Sons, 2005.
13. Cooper H, Hedges LV. The handbook of research synthesis. New York : Russell Sage Foundation, 1994.
14. Citrome L. Compelling or irrelevant? Using number needed to treat can help decide. Acta Psychiatr Scand 2008 117 : 412 419.
15. Cohen J. Statistical power analysis for the behavioral sciences. New York : Academic Press, 1969.
16. Orwin RG. A fail-safe N for effect size in meta-analysis. J Ed Stat 1983 8 : 157 159.
17. Leucht S, Barnes TRE, Kissling W, Engel RR, Correll C, Kane JM. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry 2003 160 : 1209 1222. (Pubitemid 41070936)
18. Tamminga CA, Thaker GK, Moran M, Kakigi T, Gao X-M. Clozapine in tardive dyskinesia: observations from human and animal model studies. J Clin Psychiatry 1994 55 (suppl. 9 102 106. (Pubitemid 24353029)
19. Tran PV, Dellva MA, Tollefson GD, Wentley AL, Beasley CM. Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychoses. Br J Psychiatry 1998 172 : 499 505. (Pubitemid 28247482)
20. Csernansky JG, Mahmoud R, Brenner R. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. N Engl J Med 2002 346 : 16 22. (Pubitemid 34438915)
21. Daniel DG, Wozniak P, Mack RJ, McCarthy BG. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. Psychopharmacol Bull 1998 34 : 61 69. (Pubitemid 28176303)
22. Rosenheck R, Evans D, Herz L et al. How long to wait for a response to clozapine: a comparison of time course of response to clozapine and conventional antipsychotic medication in refractory schizophrenia. Schizophr Bull 1999 25 : 709 719. (Pubitemid 30013553)
23. Glass GH. In defense of generalization. Behav Brain Sci 1978 3 : 394 395.
24. Mota Neto JIS, Lima MS, Soares BGO. Amisulpride for schizophrenia. Cochrane Database Syst Rev 2002 2 : CD001357.
25. Duggan L, Fenton M, Rathbone J, Dardennes R, El-Dosoky A, Indran S. Olanzapine for schizophrenia. Cochrane Database Syst Rev 2005 2 : CD001359.
26. Berner MM, Rüther A, Stieglitz RD, Berger M. Evidence-based medicine in psychiatry - more rational psychiatry? Nervenarzt 2000 71 : 173 180.
27. Leucht S, Arbter D, Engel RR, Kissling W, Davis JM. How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Mol Psychiatry 2008 Jan 8. [Epub ahead of print].
28. Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second generation versus first generation antipsychotics for schizophrenia: a meta-analysis. Lancet 2009 373 : 31 41.
29. Leucht S, Komossa K, Rummel-Kluge C et al. A meta-analysis of head to head comparisons of second generation antipsychotics in the treatment of schizophrenia. Am J Psychiatry 2009 166 : 152 163.
30. Heres S, Davis J, Maino K, Jetzinger E, Kissling W, Leucht S. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Am J Psychiatry 2006 163 : 185 194. (Pubitemid 44480836)
31. Marder SR, Glynn SM, Wirshing WC, et al. Maintenance treatment of schizophrenia with risperidone or haloperidol: two-year outcomes. Am J Psychiatry 2003 160 : 1405 12. (Pubitemid 41070914)
32. Speller JC, Barnes TRE, Curson DA, Pantelis C, Alberts JL. One-year, low-dose neuroleptic study of in-patients with chronic schizophrenia characterised by persistent negative symptoms - amisulpride v haloperidol. Br J Psychiatry 1997 171 : 564 568. (Pubitemid 27527328)
33. Essock SM, Hargreves WA, Covell NH, Goethe J. Clozapine's effectiveness for patients in state hospitals: results from a randomized trial. Psychopharmacol Bull 1996 32 : 683 697. (Pubitemid 26428274)